Improvement in symptoms of depression and anxiety with zuranolone treatment in patients with major depressive disorder: HAM-A analysis from the phase 3, multicenter, randomized, double-blind, placebo-controlled waterfall study

The requested reference [747ba5f5bcc3b39520564cab92bf0f15f05bf603] no longer exists in our database. It has been replaced by the current reference: [1111b361c1952535516ae4e522ca686a8c66606a]

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2021
This article has no abstract
Epistemonikos ID: 054f0a498bab30a793add5820e6c7f348f25c2cf
First added on: Apr 30, 2026